Reputation and Power : : Organizational Image and Pharmaceutical Regulation at the FDA /

Reputation and Power : : Organizational Image and Pharmaceutical Regulation at the FDA / / Daniel Carpenter.

The U.S. Food and Drug Administration is the most powerful regulatory agency in the world. How did the FDA become so influential? And how exactly does it wield its extraordinary power? Reputation and Power traces the history of FDA regulation of pharmaceuticals, revealing how the agency's organ...

Full description

Saved in:
Bibliographic Details
Superior document:Title is part of eBook package: De Gruyter DG and UP eBook Package 2000-2015
VerfasserIn:
Carpenter, Daniel,
Place / Publishing House:Princeton, NJ : : Princeton University Press, , [2014]
©2010
Year of Publication:2014
Edition:Course Book
Language:English
Series:Princeton Studies in American Politics: Historical, International, and Comparative Perspectives ; 137
Online Access:
Physical Description:1 online resource (856 p.) :; 13 halftones. 17 line illus. 13 tables.
Tags: Add Tag
No Tags, Be the first to tag this record!
Table of Contents:
  • Frontmatter
  • Contents
  • List of Illustrations
  • List of Tables
  • Acknowledgments
  • List of Abbreviations and Acronyms
  • Introduction. The Gatekeeper
  • Chapter One. Reputation and Regulatory Power
  • Part One: Organizational Empowerment and Challenge
  • Chapter Two. Reputation and Gatekeeping Authority: The Federal Food, Drug and Cosmetic Act of 1938 and Its Aftermath
  • Chapter Three. The Ambiguous Emergence of American Pharmaceutical Regulation, 1944-1961
  • Chapter Four. Reputation and Power Crystallized: Thalidomide, Frances Kelsey, and Phased Experiment, 1961-1966
  • Chapter Five. Reputation and Power Institutionalized: Scientific Networks, Congressional Hearings, and Judicial Affirmation, 1963-1986
  • Chapter Six. Reputation and Power Contested: Emboldened Audiences in Cancer and Aids, 1977-1992
  • Part Two: Pharmaceutical Regulation and Its Audiences
  • Chapter Seven. Reputation and the Organizational Politics of New Drug Review
  • Chapter Eight. The Governance of Research and Development: Gatekeeping Power, Conceptual Guidance, and Regulation by Satellite
  • Chapter Nine. The Other Side of the Gate: Reputation, Power, and Post-Market Regulation
  • Chapter Ten. The Détente of Firm and Regulator
  • Chapter Eleven. American Pharmaceutical Regulation in International Context: Audiences, Comparisons, and Dependencies
  • Chapter Twelve. Conclusion: A Reputation in Relief
  • Primary Sources and Archival Collections
  • Index

Similar Items